ClinicalTrials.gg
RecruitingNCT07453485Updated Mar 6, 2026

Immediate Effects of Neuromuscular Electrical Stimulation on Pain and Function in Achilles Tendon Disorders

An interventional study of Neuromuscular Electrical Stimulation (NMES) in Achilles Tendinopathy (AT) and Achilles Tendon Rupture, sponsored by University of Brasilia. Recruiting at 1 site in Brazil. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-03-06.

Sponsored by University of Brasilia · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Jan 2026; still recruiting 10 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

The Achilles tendon exhibits high tensile strength and can withstand extremely high loads. However, it is susceptible to injuries such as tendinopathies and ruptures, which are associated with structural alterations and loss of function. Strategies have been investigated to enhance clinical rehabilitation. Nevertheless, the effects of neuromuscular electrical stimulation on pain and functional improvement, as well as the optimal dosing parameters for the rehabilitation of Achilles tendon injuries, remain inconclusive. The aim of this study is to compare the immediate effects of two electrical stimulation protocols on pain, functional performance, peripheral oxygen extraction, and maximal tendon displacement during a single leg heel rise functional task in patients with Achilles tendinopathy and/or a history of Achilles tendon rupture. In addition, this study aims to characterize Achilles tendon structural properties and ankle plantarflexor muscle strength in this population.

Read the detailed description

All groups will be composed of participants with a primary complaint of pain and/or a history of previous Achilles tendon rupture. Participants will perform the interventions in two blocks separated by a seven-day interval (wash-out). Block A: (1) control without active intervention and (2) electrical stimulation applied at the maximum tolerated intensity. Block B: (3) control with sham stimulation and (4) sensory-level electrical stimulation. Block A will always be performed first, followed by Block B. Interventions within each block will be conducted in three sets of 10 repetitions, totaling six sets per day.

02

Conditions studied

  • Achilles Tendinopathy (AT)
  • Achilles Tendon Rupture

Browse trials for

Keywords

  • Achilles tendon
  • Achilles tendinopathy
  • Achilles tendon rupture
  • Neuromuscular electrical stimulation
  • Pain
  • Functional performance
03

In context

Pain

10,054 studies on the registry are indexed under Pain; 1,649 are open to participants now.

This study's planned enrollment of 30 is below the median of 66 across 8,493 interventional studies indexed under Pain.

Browse Pain studies →

Lead sponsor

University of Brasilia is the lead sponsor of 66 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Primary complaint of pain localized in the midportion (2-6 cm proximal to the calcaneus) or insertion of the Achilles tendon, and/or a history of Achilles tendon rupture occurring at least 3 months prior to assessment.
  • Pain on palpation of the Achilles tendon.
  • Pain during load-bearing activities

Exclusion criteria

Exclusion Criteria:

  • Exclusive diagnosis of bursitis confirmed by ultrasonographic assessment
  • Any other lower limb injury
  • History of lower limb surgery within the past year
  • Previous Achilles tendon tenoplasty performed less than 3 months prior to assessment
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
30 participants (estimated)

Study arms

  • No intervention
    Control without active intervention

    In this group, participants will perform three sets of 10 repetitions of the single leg heel rise functional task without the application of electrical stimulation. Immediately after each set, pain level, functional performance, peripheral oxygen extraction, and maximal Achilles tendon displacement will be assessed.

  • Experimental
    Electrical stimulation applied at the maximum tolerated intensity

    Under this condition, participants will perform three sets of 10 repetitions of the single leg heel rise functional task with superimposed electrical stimulation applied at the maximum tolerated intensity, characterized by visible muscle contraction and associated with a self-reported discomfort level between 8 and 10 on the Numeric Rating Scale. Immediately after each set, pain level, functional performance, peripheral oxygen extraction, and maximal Achilles tendon displacement will be assessed.

    Device: Neuromuscular Electrical Stimulation (NMES)

  • Placebo comparator
    Control with sham stimulation

    For this condition, participants will perform three sets of 10 repetitions of the single leg heel rise functional task with superimposed sham electrical stimulation. Electrical stimulation parameters will initially be configured identically to those used in the active intervention. However, to ensure adequate blinding, stimulation will be applied for approximately 40 seconds and then gradually reduced until complete cessation. From this point onward, no additional current will be delivered, although the device will remain on and the electrodes will remain in place throughout the test. Immediately after each set, pain level, functional performance, peripheral oxygen extraction, and maximal Achilles tendon displacement will be assessed.

    Device: Neuromuscular Electrical Stimulation (NMES)

  • Active comparator
    Sensory-level electrical stimulation

    In this condition, participants will perform three sets of 10 repetitions of the single leg heel rise functional task with superimposed electrical stimulation applied at the sensory level, defined as the highest intensity that does not elicit visible muscle contraction. Immediately after each set, pain level, functional performance, peripheral oxygen extraction, and maximal Achilles tendon displacement will be assessed.

    Device: Neuromuscular Electrical Stimulation (NMES)

Interventions

  • DeviceNeuromuscular Electrical Stimulation (NMES)

    Neuromuscular electrical stimulation-induced contractions will be delivered using an electrical stimulator connected to a pair of 5×5 cm self-adhesive surface electrodes. Stimulation will be applied in a superimposed manner during voluntary movement, at a frequency of 75 Hz and a phase duration of 400 µs.

06

What researchers measure

Primary outcomes

  1. Pain level

    Pain intensity during the single leg heel rise task will be assessed using the Visual Analog Scale, consisting of a numerical scale ranging from 0 to 10 points, in which 0 represents no pain and 10 corresponds to the worst pain ever experienced by the participant.

    Time frame: Immediately after the performance of the functional task

Secondary outcomes

  1. Total time

    The total time (s) during the single-leg heel rise task will be measured using the MuscleLab® system.

    Time frame: Immediately after the performance of the functional task.

  2. Maximal displacement

    The maximal displacement (cm) during the single-leg heel rise task will be measured using the MuscleLab® system.

    Time frame: Immediately after the performance of the functional task.

  3. Total work

    The total work (J) during the single-leg heel rise task will be measured using the MuscleLab® system.

    Time frame: Immediately after the performance of the functional task.

  4. Total power

    The total power (W) during the single-leg heel rise task will be measured using the MuscleLab® system.

    Time frame: Immediately after the performance of the functional task.

  5. Number of repetitions

    The number of repetitions completed during the single-leg heel rise task will be recorded using the MuscleLab® system.

    Time frame: Immediately after the performance of the functional task.

  6. Peripheral oxygen extraction

    Oxygen extraction of the periarticular ankle muscles will be assessed using near-infrared spectroscopy, with the sensor positioned on the skin over the lateral gastrocnemius muscle during the single leg heel rise task. Variations in oxy- and deoxy-hemo/myoglobin (O₂Hb and HHb, respectively) will be recorded in arbitrary units at a sampling frequency of 25 Hz.

    Time frame: Immediately after the performance of the functional task.

  7. Maximal Achilles tendon displacement

    Maximal Achilles tendon displacement (%) will be measured using a transducer positioned over the myotendinous junction of the gastrocnemius muscles, secured to a specific support, during the single leg heel rise task. Maximal displacement will be determined based on the change in Achilles tendon length relative to its resting length.

    Time frame: Immediately after the performance of the functional task.

  8. Lenght of achilles tendon

    The total and free length (cm) of the Achilles tendon will be measured using portable ultrasonography.

    Time frame: Baseline (prior to Block A only)

  9. Thickness of achilles tendon

    The thickness (mm) of the Achilles tendon will be measured using portable ultrasonography.

    Time frame: Baseline (prior to Block A only)

  10. Cross-sectional area of achilles tendon

    The cross-sectional area (cm²) of the Achilles tendon will be measured using portable ultrasonography.

    Time frame: Baseline (prior to Block A only)

  11. Presence of neovascularization of the Achilles tendon

    The presence of neovascularization of the Achilles tendon will be assessed using portable ultrasonography.

    Time frame: Baseline (prior to Block A only)

  12. Elastic modulus

    The median elastic modulus (kPa) of the Achilles tendon will be measured using shear wave elastography.

    Time frame: Baseline (prior to Block A only)

  13. Shear wave velocity

    The median shear wave velocity (m/s) of the Achilles tendon will be measured using shear wave elastography.

    Time frame: Baseline (prior to Block A only)

  14. Depth

    The measurement depth (cm) of the Achilles tendon during elastography assessment will be recorded using shear wave elastography.

    Time frame: Baseline (prior to Block A only)

  15. Isometric strength

    Isometric strength will be assessed using an isokinetic dynamometer, based on peak isometric torque (N/m) during plantar flexion at 0°.

    Time frame: Baseline (prior to Block A only)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2026 (actual). Primary completion is estimated for Aug 2029, 43 months after the start.

Of 3,731 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 43 months is above that.

Counting every sponsor, half of 3,830 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 13, 2026
First posted
Mar 6, 2026
StartActual
Jan 6, 2026
Primary completionEst.
Aug 30, 2029
CompletionEst.
Dec 30, 2029
Last update
Mar 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07453485
Lead sponsor
University of Brasilia
Responsible party
Sponsor
First posted
Mar 6, 2026
Start date
Jan 6, 2026
Primary completion
Aug 30, 2029 (estimated)
Completion
Dec 30, 2029 (estimated)
Last update
Mar 6, 2026

Study contacts

João LQ Durigan, PhD
Contact
joaodurigan@gmail.com
+55 61 3107-8450
José RS Júnior, PhD
Contact
joserobertofisio@gmail.com
+55 61 3107-8450

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion